Coronary circulatory dysfunction, cardiac sarcoidosis, endocannabinoid system in obesity, myocardial cannabinoid type 1 receptor, hypertrophic obstructive cardiomyopathy, myocardial angiotensin II type 1 receptor, cardiac computed tomography, cardiac magnetic resonance imaging.

PET and SPECT in cardiovascular disease, ischemic heart disease, cardiac viability, myocarditis, vascular Inflammation, chest pain, microvascular angina,  heart failure, cardiac sarcoidosis, syndrome X, microvascular dysfunction.

• Information for Patients